Showing results (231-240 of 276) with videos related to

Sort By:
Pageof 28
Blood Advances|September 6, 2023
Nonrelapse mortality after CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registryJean Lemoine, Emmanuel Bachy, Guillaume Cartron, et al.
Blood|September 19, 2022
Outcomes of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T analysisRoberta Di Blasi, Steven Le Gouill, Emmanuel Bachy, et al.
Blood|December 22, 2021
Obinutuzumab plus lenalidomide in advanced, previously untreated follicular lymphoma in need of systemic therapy: a LYSA studyEmmanuel Bachy, Roch Houot, Pierre Feugier, et al.
Cancers|September 28, 2021
Deep-Learning Assessed Muscular Hypodensity Independently Predicts Mortality in DLBCL Patients Younger Than 60 YearsMaxime Jullien, Benoit Tessoulin, Hervé Ghesquières, et al.
Bone Marrow Transplantation|January 19, 2020
Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centersThomas Hueso, Thomas Gastinne, Sylvain Garciaz, et al.
The Lancet. Haematology|September 24, 2020
Molecular response after obinutuzumab plus high-dose cytarabine induction for transplant-eligible patients with untreated mantle cell lymphoma (LyMa-101): a phase 2 trial of the LYSA groupSteven Le Gouill, Asma Beldi-Ferchiou, Marion Alcantara, et al.
British Journal of Haematology|February 17, 2023
Efficacy of a short sandwich protocol, methotrexate, gemcitabine, L-asparaginase and dexamethasone chemotherapy combined with radiotherapy, in localised newly diagnosed NK/T-cell lymphoma: A French retrospective studySammara Chaubard, Amira Marouf, David Lavergne, et al.
Acta Oncologica (Stockholm, Sweden)|October 10, 2022
Outcomes after allogeneic hematopoietic stem cell transplantation for adults with primary mediastinal B cell lymphoma: a SFGM-TC and LYSA studyBaptiste Le Calvez, Benoit Tessoullin, Loïc Renaud, et al.
Blood Advances|November 12, 2020
Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphomaLaetitia Vercellino, Roberta Di Blasi, Salim Kanoun, et al.
Acta Oncologica (Stockholm, Sweden)|October 28, 2020
Grade 2 acute GVHD is a factor of good prognosis in patients receiving peripheral blood stem cells haplo-transplant with post-transplant cyclophosphamidePatrice Chevallier, Ana Berceanu, Pierre Peterlin, et al.
Pageof 28